Gorantla S - Search Results

1

An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.

Gong Y, Zhi K, Nagesh PKB, Sinha N, Chowdhury P, Chen H, Gorantla S, Yallapu MM, Kumar S. Gong Y, et al. Among authors: gorantla s. Viruses. 2020 May 20;12(5):564. doi: 10.3390/v12050564. Viruses. 2020. PMID: 32443728 Free PMC article.

2

Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain.

Dou H, Morehead J, Bradley J, Gorantla S, Ellison B, Kingsley J, Smith LM, Chao W, Bentsman G, Volsky DJ, Gendelman HE. Dou H, et al. Among authors: gorantla s. Glia. 2006 Aug 1;54(2):81-93. doi: 10.1002/glia.20358. Glia. 2006. PMID: 16705672

3

Rodent models for HIV-associated neurocognitive disorders.

Gorantla S, Poluektova L, Gendelman HE. Gorantla S, et al. Trends Neurosci. 2012 Mar;35(3):197-208. doi: 10.1016/j.tins.2011.12.006. Epub 2012 Feb 1. Trends Neurosci. 2012. PMID: 22305769 Free PMC article. Review.

4

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.

Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE. Kanmogne GD, et al. Among authors: gorantla s. Int J Nanomedicine. 2012;7:2373-88. doi: 10.2147/IJN.S29454. Epub 2012 May 8. Int J Nanomedicine. 2012. PMID: 22661891 Free PMC article.

5

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

Dash PK, Gendelman HE, Roy U, Balkundi S, Alnouti Y, Mosley RL, Gelbard HA, McMillan J, Gorantla S, Poluektova LY. Dash PK, et al. Among authors: gorantla s. AIDS. 2012 Nov 13;26(17):2135-44. doi: 10.1097/QAD.0b013e328357f5ad. AIDS. 2012. PMID: 22824628 Free PMC article.

6

Amphiphilic cationic nanogels as brain-targeted carriers for activated nucleoside reverse transcriptase inhibitors.

Warren G, Makarov E, Lu Y, Senanayake T, Rivera K, Gorantla S, Poluektova LY, Vinogradov SV. Warren G, et al. Among authors: gorantla s. J Neuroimmune Pharmacol. 2015 Mar;10(1):88-101. doi: 10.1007/s11481-014-9576-7. Epub 2015 Jan 6. J Neuroimmune Pharmacol. 2015. PMID: 25559020 Free PMC article.

7

HIV-1 cellular and tissue replication patterns in infected humanized mice.

Araínga M, Su H, Poluektova LY, Gorantla S, Gendelman HE. Araínga M, et al. Among authors: gorantla s. Sci Rep. 2016 Mar 21;6:23513. doi: 10.1038/srep23513. Sci Rep. 2016. PMID: 26996968 Free PMC article.

8

Smoothened Agonist Reduces Human Immunodeficiency Virus Type-1-Induced Blood-Brain Barrier Breakdown in Humanized Mice.

Singh VB, Singh MV, Gorantla S, Poluektova LY, Maggirwar SB. Singh VB, et al. Among authors: gorantla s. Sci Rep. 2016 May 31;6:26876. doi: 10.1038/srep26876. Sci Rep. 2016. PMID: 27241024 Free PMC article.

9

A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.

Araínga M, Edagwa B, Mosley RL, Poluektova LY, Gorantla S, Gendelman HE. Araínga M, et al. Among authors: gorantla s. Retrovirology. 2017 Mar 9;14(1):17. doi: 10.1186/s12977-017-0344-7. Retrovirology. 2017. PMID: 28279181 Free PMC article.

10

Human Interleukin-34 facilitates microglia-like cell differentiation and persistent HIV-1 infection in humanized mice.

Mathews S, Branch Woods A, Katano I, Makarov E, Thomas MB, Gendelman HE, Poluektova LY, Ito M, Gorantla S. Mathews S, et al. Among authors: gorantla s. Mol Neurodegener. 2019 Mar 5;14(1):12. doi: 10.1186/s13024-019-0311-y. Mol Neurodegener. 2019. PMID: 30832693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page